| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ed28726de9f916f355f8adc331e736b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8bf81058ac17e22935e6557d357a86c4 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-405
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-405
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-403
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16 |
| filingDate |
1999-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ad701b6aa296b5399a736151bdeced2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a60dfe4ad64430feeb30177625c04fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cbe9bd19e07c4be57ecee10ec48f20f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1408fbd4cc69db41c546f730130c6952 |
| publicationDate |
2004-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EA-005244-B1 |
| titleOfInvention |
INDOL-3-PROPIONAL ACIDS, THEIR SALTS AND AIRS USED AS DRUGS |
| abstract |
The cytotoxic effects of amyloid beta protein on cells are prevented by contacting the cells with an effective amount of indole-3-propionic acid or its salt or ester. In addition, it is possible to treat fibrillogenic disease in humans by administering indole-3-propionic acid or its salt or ester to the person in an amount effective to prevent or reverse fibrillogenesis. Oxidation in a biological sample can be reduced by contacting the biological sample with an effective amount of indole-3-propionic acid or a salt or ester thereof. Additionally, diseases or other conditions where free radicals and / or oxidative stress play a role can be treated by administering an effective amount of indole-3-propionic acid or its salt or ester. |
| priorityDate |
1998-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |